A Clinical Study Experiences of Cholangiocarcinoma Patients To Identify Trial Attributes Affecting Completion Rates For Specific Demographic Groups
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 主要终点
- Number of Cholangiocarcinoma patients who remain in clinical trial until completion.
研究概览
简要总结
The main reason for conducting this research is to gain a better understanding of why some people with cholangiocarcinoma are not able to participate in or complete clinical trials. Historically, certain groups of people have been more likely to participate in clinical trials, but there hasn't been much research to understand why this is the case.
The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it through. The data will be evaluated through different demographic lenses and identify trends that could help improve the experience of future cholangiocarcinoma patients during clinical trials.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient is at least 18 years of age
- •Participant has a diagnosis of Cholangiocarcinoma
- •Patient has self-identified as planning to enroll in an interventional Cholangiocarcinoma clinical trial
- •Patient must provide written informed consent
排除标准
- •No diagnosis of Cholangiocarcinoma confirmed
- •Inability to perform regular electronic reporting
- •Women who are pregnant, intend to become pregnant, or are lactating
- •Patient does not understand, sign, and return consent form
结局指标
主要结局
Number of Cholangiocarcinoma patients who remain in clinical trial until completion.
时间窗: 12 months
Rate of patients who decide to enroll in a Cholangiocarcinoma Clinical Study.
时间窗: 3 months
次要结局
未报告次要终点